Commit To Purchase Praxis Precision Medicines At $45, Earn 48.6% Annualized Using Options
July 19, 2024 at 12:09 PM EDT
Investors considering a purchase of Praxis Precision Medicines Inc (PRAX) stock, but cautious about paying the going market price of $55.06/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2025 put at the $45 strike, which has a bid at the time of this writing of $13.00..